10.1016/j.expneurol.2023.114348 125 YiB.SuK.CaiY.ChenX.BaoY.WenZ
Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, which is the active ingredient in Eli Lilly's Mounjaro and Zepbound, are considered GLP-1 drugs
However, simultaneous initiation is acceptable in motivated patients requiring rapid glycaemic improvement
doi: 10.1210/en.2014-1314
I find that most of my patients [using GLP-1s for addiction] require higher doses to really raise up their dopamine enough that theyre not having to use their addiction to spike the dopamine, she says
Staying on the drugs also did not appear to substantially increase the risks for low or high birth weight or major congenital malformations, although estimates for these outcomes were imprecise